Human mesenchymal stem cells-current trends and future prospective

I Ullah, RB Subbarao, GJ Rho - Bioscience reports, 2015 - portlandpress.com
Stem cells are cells specialized cell, capable of renewing themselves through cell division
and can differentiate into multi-lineage cells. These cells are categorized as embryonic stem …

Tuberculosis a globalized disease

RO Nyarko, A Prakash, N Kumar, P Saha… - Asian Journal of …, 2021 - ajprd.com
One of the deadliest infectious diseases in the world that causes millions of deaths per year
is tuberculosis (TB). In this document we present an overview of TB including pathogenesis …

Stem cells in the treatment of diabetes mellitus—Focus on mesenchymal stem cells

G Päth, N Perakakis, CS Mantzoros, J Seufert - Metabolism, 2019 - Elsevier
Diabetes mellitus type 1 and type 2 have become a global epidemic with dramatically
increasing incidences. Poorly controlled diabetes is associated with severe life-threatening …

Stem cell therapy to cure type 1 diabetes: from hype to hope

P Chhabra, KL Brayman - Stem cells translational medicine, 2013 - academic.oup.com
Type 1 diabetes mellitus (T1D) is a chronic, multifactorial autoimmune disease that involves
the progressive destruction of pancreatic β-cells, ultimately resulting in the loss of insulin …

Exosomes derived from bone marrow mesenchymal stem cells harvested from type two diabetes rats promotes neurorestorative effects after stroke in type two …

P Venkat, A Zacharek, J Landschoot-Ward… - Experimental …, 2020 - Elsevier
Background and purpose Diabetes elevates the risk of stroke, promotes inflammation, and
exacerbates vascular and white matter damage post stroke, thereby hindering long term …

Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow-derived mesenchymal stem/stromal cells

LT Nguyen, DM Hoang, KT Nguyen… - Stem Cells …, 2021 - academic.oup.com
Human bone marrow-derived mesenchymal stem/stromal cells (BM-MSCs) represent
promising stem cell therapy for the treatment of type 2 diabetes mellitus (T2DM), but the …

From mesenchymal stromal/stem cells to insulin-producing cells: progress and challenges

MA Ghoneim, AF Refaie, BL Elbassiouny… - Stem Cell Reviews and …, 2020 - Springer
Mesenchymal stromal cells (MSCs) are an attractive option for cell therapy for type 1
diabetes mellitus (DM). These cells can be obtained from many sources, but bone marrow …

Effects of fine particulate matter on bone marrow-conserved hematopoietic and mesenchymal stem cells: a systematic review

G Bhattarai, SK Shrestha, HJ Sim, JC Lee… - … & Molecular Medicine, 2024 - nature.com
The harmful effects of fine particulate matter≤ 2.5 µm in size (PM2. 5) on human health have
received considerable attention. However, while the impact of PM2. 5 on the respiratory and …

Application of mesenchymal stem cells in inflammatory and fibrotic diseases

JS Ryu, EJ Jeong, JY Kim, SJ Park, WS Ju… - International Journal of …, 2020 - mdpi.com
Mesenchymal stem cells (MSCs) are multipotent stem cells that can be isolated from various
tissues in the adult body. MSCs should be characterized by three criteria for regenerative …

Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors

RR Bhonde, P Sheshadri, S Sharma… - The international journal of …, 2014 - Elsevier
Generation of surrogate β-cells is the need of the day to compensate the short supply of
islets for transplantation to diabetic patients requiring daily shots of insulin. Over the years …